Showing results (301-310 of 308) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 308 results.
Cell Reports. Medicine|June 2, 2022
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescentsPablo Garcia-Valtanen, Christopher M Hope, Makutiro G Masavuli, et al.
Journal of Medicinal Chemistry|December 11, 2012
3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo modelsMichael Soth, Johannes C Hermann, Calvin Yee, et al.
Internal Medicine Journal|November 16, 2020
COVID-19 in Australia: our national response to the first cases of SARS-CoV-2 infection during the early biocontainment phaseRamon Z Shaban, Cecilia Li, Matthew V N O'Sullivan, et al.
Open Forum Infectious Diseases|April 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across AustraliaDao Sen Wang, Amy Phu, Kristen McKee, et al.
The Lancet. Digital Health|December 21, 2024
The importance of microbiology reference laboratories and adequate funding for infectious disease surveillanceDavid Shaw, Raquel Abad Torreblanca, Zahin Amin-Chowdhury, et al.
The Lancet. Digital Health|July 29, 2023
Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS ConsortiumDavid Shaw, Raquel Abad, Zahin Amin-Chowdhury, et al.
The Lancet. Digital Health|May 28, 2021
Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the Invasive Respiratory Infection Surveillance Initiative: a prospective analysis of surveillance dataAngela B Brueggemann, Melissa J Jansen van Rensburg, David Shaw, et al.
JAMA|September 3, 2020
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19: The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical TrialDerek C Angus, Lennie Derde, Farah Al-Beidh, et al.
Pageof 31